
    
      Using US claims data from the HealthCore Integrated Research Environment, COPD patients â‰¥40
      years old initiating BFC or tiotropium between 3/1/2009-2/28/2012 and considered at risk for
      a future exacerbation were identified and followed for 12 months.
    
  